Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 11, 2015
CNS biomarkers: Potential from a regulatory perspective: Case study - Focus in low hippocampus volume as a biomarker measured by MRIMaria Isaac, Christine Gispen-de WiedEuropean Journal of Pharmacology|October 20, 2009
Empathy dysfunction in children and adolescents with disruptive behavior disordersMinet de Wied, Christine Gispen-de Wied, Anton van BoxtelEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 12, 2009
Psychopharmacology for children: from off label use to registrationTamar Wohlfarth, Luuk Kalverdijk, Carin Rademaker, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 19, 2010
Insomnia medication: do published studies reflect the complete picture of efficacy and safety?Taina Mattila, Violeta Stoyanova, André Elferink, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 19, 2012
The placebo arm in clinical studies for treatment of psychiatric disorders: a regulatory dilemmaChristine Gispen-de Wied, Violeta Stoyanova, Yang Yu, et al.Journal of Clinical Pharmacology|September 8, 2018
Dose-Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective AnalysisYvonne Schuller, Christine Gispen-de Wied, Carla E M Hollak, et al.Drug Safety|November 5, 2011
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agenciesIneke Crijns, Sabine Straus, Michiel Luteijn, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 13, 2010
The EU paediatric regulation: effects on paediatric psychopharmacology in EuropeVioleta V Stoyanova-Beninska, Tamar Wohlfarth, Maria Isaac, et al.Drug Discovery Today|September 26, 2017
European regulatory use and impact of subgroup evaluation in marketing authorisation applicationsJulien Tanniou, Steven Teerenstra, Sagal Hassan, et al.Journal of Clinical Psychopharmacology|January 15, 2009
HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication studyHans Mulder, Dan Cohen, Hans Scheffer, et al.Pageof 2